Cefixime and Levofloxacin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefixime (cefixime) and Levofloxacin (levofloxacin; sodium chloride). Common drug interactions include gastrointestinal haemorrhage among females and pyrexia among males.

The phase IV clinical study analyzes what interactions people have when they take Cefixime and Levofloxacin. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 3,237 Cefixime users. Check the latest studies of Cefixime.

What is Levofloxacin?

Levofloxacin has active ingredients of levofloxacin; sodium chloride. It is often used in sinusitis. eHealthMe is studying from 16,335 Levofloxacin users. Check the latest studies of Levofloxacin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

17 people who take Cefixime and Levofloxacin together, and have interactions are studied.

Cefixime and Levofloxacin drug interactions.

What are the common drug interactions of Cefixime and Levofloxacin, by gender? *:

female:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Asthenia (weakness)
  3. Nausea (feeling of having an urge to vomit)
  4. Renal failure acute (rapid kidney dysfunction)
  5. Vomiting

male:

  1. Pyrexia (fever)
  2. Cardiac disorder
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Hypotension (abnormally low blood pressure)
  5. Infusion related reaction
  6. Metastases to bone (cancer spreads to bone)
  7. Prostatitis (inflammation of the prostate gland)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)

What are the common drug interactions of Cefixime and Levofloxacin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Appendicitis (inflammation of the appendix)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Gastroenteritis (inflammation of stomach and intestine)
  4. Hypotension (abnormally low blood pressure)
  5. Infusion related reaction
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)
  8. Abdominal pain
  9. Drug toxicity
  10. Vomiting

20-29:

n/a

30-39:

n/a

40-49:

  1. Colitis pseudomembranous (antibiotic-associated diarrhoea)
  2. Diarrhoea

50-59:

n/a

60+:

  1. Pyrexia (fever)
  2. Cardiac disorder
  3. Renal failure acute (rapid kidney dysfunction)
  4. Tendonitis (a condition that causes pain and swelling of tendons)
  5. Colitis pseudomembranous (antibiotic-associated diarrhoea)
  6. Lung disorder (lung disease)
  7. Methicillin-resistant staphylococcal aureus infection
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Sudden death
  10. Cough

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 3 people, 17.65%
  2. Urinary Tract Infection: 2 people, 11.76%
  3. Tracheitis (an inflammation of the trachea): 2 people, 11.76%
  4. Supraventricular Extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle): 2 people, 11.76%
  5. Osteoporosis (bones weak and more likely to break): 2 people, 11.76%
  6. Kidney Infection (Pyelonephritis): 2 people, 11.76%
  7. High Blood Pressure: 2 people, 11.76%
  8. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 11.76%
  9. Dyslipidaemia (abnormal amount of lipids): 2 people, 11.76%
  10. Aplastic Anemia: 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and Levofloxacin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefixime and Levofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levofloxacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefixime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levofloxacin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefixime and levofloxacin; sodium chloride (the active ingredients of Cefixime and Levofloxacin, respectively), and Cefixime and Levofloxacin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: